How Should Canadian Pharmacy Departments Utilize Idarucizumab?
Department of Pharmacy Services Regina Qu'Appelle Health Region Regina, Saskatchewan.
Kirsten
K
Tangedal
Department of Pharmacy Services Regina Qu'Appelle Health Region Regina, Saskatchewan.
William
W
Semchuk
Department of Pharmacy Services Regina Qu'Appelle Health Region Regina, Saskatchewan.
Jennifer
J
Bolt
D000284:Administration, Oral; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000627:therapeutic use*; D000991:Antithrombins / Q000009:adverse effects; D002170:Canada; D000069604:Dabigatran / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D004334:Drug Administration Schedule; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006487:Hemostasis; D006801:Humans; D010607:Pharmacy Service, Hospital; D017410:Practice Guidelines as Topic
D061067:Antibodies, Monoclonal, Humanized; D000991:Antithrombins; C000594745:idarucizumab; D000069604:Dabigatran